ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CVSG.GB CVS Group Plc

835.00
10.00 (1.21%)
24 Dec 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type Share ISIN Share Description
CVS Group Plc AQSE:CVSG.GB Aquis Stock Exchange Ordinary Share GB00B2863827 Ordinary Shares 20p
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  10.00 1.21% 835.00 620.00 1,050.00 835.00 815.00 815.00 130 12:33:49
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

CVS Group plc Directorate Change (4591R)

27/10/2023 7:00am

UK Regulatory


CVS (AQSE:CVSG.GB)
Historical Stock Chart


From Dec 2022 to Dec 2024

Click Here for more CVS Charts.

TIDMCVSG

RNS Number : 4591R

CVS Group plc

27 October 2023

For Immediate Release 27 October 2023

CVS Group plc

("CVS" or the "Group")

Directorate Change

CVS, the UK listed veterinary group and a leading provider of veterinary services, announces that its Chair Richard Connell has taken the difficult decision to resign with immediate effect due to ill health .

Deborah Kemp, the Group's Senior Independent Director will assume the role of Chair for the interim period whilst the Board commences a process to appoint a permanent successor.

The Board will make a further announcement at the appropriate time.

CEO Richard Fairman commented: "On behalf of the Board and colleagues at CVS, I would like to thank Richard for his significant contribution during his tenure as Chair and for his support to me personally. Richard has played a pivotal role in overseeing considerable growth in the Group over the past 16 years and will be sorely missed. We wish Richard a full and speedy recovery."

Contacts

CVS Group plc via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Ben Wright / James Thompson / Milo Bonser

Camarco (Financial PR)

Geoffrey Pelham-Lane +44 (0)7733 124 226

Ginny Pulbrook +44 (0)7961 315 138

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAFEIFMMEDSEFS

(END) Dow Jones Newswires

October 27, 2023 02:00 ET (06:00 GMT)

1 Year CVS Chart

1 Year CVS Chart

1 Month CVS Chart

1 Month CVS Chart

Your Recent History

Delayed Upgrade Clock